In the Lab Theresa Gaffney Unprecedented! Incredible! Scientific grant applications are getting heavier on hype
Politics Lev Facher Cities are lobbying to host the ARPA-H headquarters. Experts don’t understand why
Politics Rachel Cohrs A Democratic Senate improves the outlook for Biden health and science priorities, including key nominees
Special Report Jonathan Wosen ‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia
Pharmalot Ed Silverman Lawmakers push NIH to disclose steps being taken to ensure clinical trial results are reported
D.C. Diagnosis Edward Chen A chaotic sprint to lower insulin prices and AIDS activists go after Biden on monkeypox
Exclusive Lev Facher In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans
Politics Lev Facher Congress is closer than ever to formally authorizing ARPA-H. But the details aren’t as final as they seem
Politics Lev Facher Francis Collins: Concern about independence of new moonshot science agency ARPA-H are ‘overblown’
Politics Lev Facher The panel was supposed to improve efficiency at the NIH. It hasn’t even met for 7 years
Politics Lev Facher A new nonprofit wants to rewrite the playbook for how the U.S. government funds science
Politics Nicholas Florko CDC, FDA, and NIH staffers aren’t reporting political interference, new watchdog report shows
Politics Lev Facher Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on
Exclusive Lev Facher Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence
Pharmalot Ed Silverman Facing intense criticism, Moderna pauses bitter dispute with the NIH over Covid-19 vaccine patents
Politics Lev Facher NIH’s Francis Collins: For Biden’s new research agency to succeed, it should prepare for some projects to fail
Health Kate Sheridan Ginkgo Bioworks, Mammoth Biosciences among winners of NIH’s ‘Shark Tank’ for Covid-19 tests
First Opinion Jennifer Spotila The NIH is thwarting research on a poorly understood yet serious condition
Exclusive Sharon Begley and Andrew Joseph New alcohol-advertising research stopped with NIH branch director’s arrival